EPA has a stronger direct anti-inflammatory effect than DHA in most contexts, but the full picture is more nuanced. Both omega-3 fatty acids reduce inflammation through overlapping and distinct pathways, and the best approach for most people involves getting both. That said, when researchers isolate the two, EPA consistently shows more potent activity against the kind of systemic inflammation measured by blood markers like TNF-alpha and IL-6.
How EPA and DHA Fight Inflammation Differently
EPA and DHA don’t do the same thing inside your cells. They produce different sets of anti-inflammatory compounds, interact with cell membranes differently, and resolve inflammation through separate mechanisms. Understanding these differences helps explain why one may outperform the other depending on the type of inflammation you’re dealing with.
EPA competes directly with arachidonic acid, a fatty acid your body uses to produce inflammatory signaling molecules. When EPA wins that competition, the resulting molecules are dramatically weaker. For example, one key inflammatory signal produced from EPA is 10 to 100 times less potent at attracting immune cells to an injury site than the equivalent signal made from arachidonic acid. EPA-derived compounds can also actively block the effects of arachidonic acid’s inflammatory products, giving EPA a two-pronged advantage: it produces weaker inflammatory signals while suppressing the stronger ones.
DHA takes a somewhat different approach. It’s the precursor to protectins and maresins, specialized compounds that don’t just dampen inflammation but actively initiate tissue repair and push your body toward resolution. Protectin D1, for instance, suppresses the production of TNF-alpha and IL-1 beta, two of the most important inflammatory cytokines. DHA also makes up a large portion of brain cell membranes, giving it a unique role in neuroinflammation that EPA can’t fully replicate.
Both EPA and DHA produce resolvins, another class of inflammation-resolving compounds. EPA gives rise to E-series resolvins, while DHA produces D-series resolvins. Both types block immune cells from flooding into inflamed tissue. Together, these pathways don’t merely suppress inflammation. They help your body clean up and recover from it.
What Happens at the Cell Membrane Level
EPA and DHA behave very differently once they’re embedded in cell membranes, and this matters for how they influence inflammatory signaling. EPA adopts a relatively straight, extended shape that stabilizes the surrounding membrane structure. DHA, with its extra double bond and two additional carbon atoms, stays in a curved conformation that disrupts the membrane’s interior and increases its fluidity in a dose-dependent way.
These physical differences have real consequences. EPA’s stabilizing effect on membranes changes how signaling proteins are organized within them, including proteins involved in producing nitric oxide (a molecule that relaxes blood vessels and modulates immune responses). DHA’s membrane-disrupting behavior pushes cholesterol into separate clusters, increasing membrane elasticity and altering how signals pass through the cell surface. When both EPA and DHA are present together, their effects on membrane structure are distinct from what either does alone, which may explain why supplements combining both sometimes produce different results than pure EPA supplements in clinical trials.
Effects on Blood Inflammatory Markers
When researchers measure standard inflammatory markers in the blood, the picture tilts toward EPA, though not as dramatically as you might expect. In a randomized controlled trial of healthy adults, EPA and DHA supplementation at 1,800 mg per day produced a 10% reduction in TNF-alpha from baseline, though none of the dose groups reached statistical significance compared to placebo. There were no significant effects on IL-6 or CRP at any dose.
An interesting finding from that same trial: when researchers looked at the omega-3 content already present in participants’ red blood cell membranes, higher levels of DHA were associated with significantly lower TNF-alpha concentrations. Higher levels of arachidonic acid were linked to higher TNF-alpha. But EPA levels in cell membranes showed no significant association with any inflammatory marker. This suggests DHA may play a more important background role in keeping baseline inflammation low, even if EPA is more effective at actively suppressing inflammatory flare-ups.
Both EPA and DHA reduce inflammation-related gene activity by inhibiting the NF-kB signaling pathway, one of the master switches your body uses to turn on inflammatory responses. In cell culture studies, both fatty acids suppress TNF-alpha production when immune cells are stimulated. The overlapping mechanisms make it difficult to declare a clear winner from blood markers alone.
Inflammation in Joints
Rheumatoid arthritis is one of the most studied conditions when it comes to omega-3s and inflammation. A 2025 meta-analysis found that fatty acid supplementation (predominantly EPA and DHA from fish oil) significantly improved disease activity scores, reduced tender joint counts, and improved physical function compared to controls. The reduction in tender joint count was clinically meaningful, with a pooled decrease of about 2.5 joints.
Most clinical trials in RA use combined EPA and DHA supplements, typically providing 1.8 to 2.1 grams of EPA and 1.2 grams of DHA daily, reflecting a ratio that favors EPA. This isn’t accidental. The rationale is that EPA’s direct competition with arachidonic acid in joint tissue makes it the more important fatty acid for reducing the inflammatory cascade that drives joint swelling and tenderness. However, pain scores (measured by visual analog scales) did not significantly improve, suggesting that omega-3s address the inflammatory component of joint disease but not all the factors that contribute to pain perception.
Inflammation in the Brain
DHA has a clear advantage when it comes to the brain. It’s the dominant omega-3 in brain tissue and plays a structural role that EPA does not. Both fatty acids contribute to cerebral blood flow through vasoactive molecules, and higher omega-3 levels in blood are associated with increased regional blood flow in the brain. But DHA’s specialized resolving compounds, particularly the protectins, are uniquely positioned to address neuroinflammation because DHA is already abundant in brain cell membranes where these compounds are produced.
This doesn’t mean EPA is irrelevant to brain health. EPA has shown benefits for mood disorders in clinical trials, potentially through its systemic anti-inflammatory effects that reduce the peripheral inflammation contributing to depression. But for conditions driven by inflammation within the brain itself, DHA’s structural presence gives it a home-court advantage.
How Much You Need for Anti-Inflammatory Effects
The doses used in clinical trials targeting inflammation are substantially higher than what most people get from diet alone. For rheumatoid arthritis, effective trials typically use 1.8 to 2.1 grams of EPA combined with 1.2 grams of DHA daily, taken for 12 to 16 weeks alongside standard medications. The American Heart Association recommends about 1 gram per day of combined EPA and DHA for people with existing heart disease.
The FDA specifies that supplement labels should not recommend more than 2 grams per day of combined EPA and DHA. Most over-the-counter fish oil capsules contain far less omega-3 than their total oil content suggests, so checking the EPA and DHA amounts on the supplement facts panel (not just the “fish oil” amount) is important if you’re trying to reach therapeutic levels.
If your primary concern is systemic inflammation from a condition like rheumatoid arthritis or cardiovascular disease, a supplement with a higher EPA-to-DHA ratio (roughly 2:1) aligns with what most successful clinical trials have used. If you’re more concerned about brain health or neuroinflammation, prioritizing DHA makes more sense given its structural role in brain tissue. For general anti-inflammatory benefits, a combination of both covers the broadest range of pathways.
Why Combining Both Still Makes Sense
Despite EPA’s edge in direct anti-inflammatory potency, taking EPA alone may not be the best strategy. The two fatty acids produce different classes of resolving compounds, interact with cell membranes in complementary ways, and address inflammation at different stages. EPA is better at preventing inflammatory signals from being generated in the first place. DHA is better at actively resolving inflammation once it’s underway and repairing the tissue damage left behind.
There’s also an important membrane interaction to consider. When both EPA and DHA are present in cell membranes together, their combined structural effects are attenuated compared to what each does separately. This modulating effect may actually be beneficial, preventing the kind of excessive membrane disruption that very high doses of DHA alone can cause. The clinical evidence broadly supports using both, with the ratio adjusted based on whether your inflammatory concern is systemic, joint-related, or neurological.